Inference of upstream-mutation and metabolomic-signature causality identifies prognostic biomarkers and therapeutic targets in pancreatic cancer

F Feng Chen X Xiaoying Lou X Xingting Guo Y Ye Guo Y Yuan Huang K Kexin Li Y Yan Song (State Key Laboratory of Membrane Biology, School of Life Sciences, Peking University) J Jiangtao Li J Jing Wang (Hunan Cancer Hospital Changsha China) K Kai Lin R Ruijun Tian (Taizhou Research Institute) M Min Wang X Xudong Dai H Hezhi Fang W Wei Cui (Department of Pharmacology, School of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University)